A new drug called AF-130 has been developed that offers “two-for-one” treatment of heart failure and sleep apnea by targeting the nervous activity that drives both. newatlas.com Submitted by chrisdh79 t3_127m0gx on March 31, 2023 at 1:46 PM in science 44 comments 702
Hellspawn54 t1_jegpcgc wrote on March 31, 2023 at 9:57 PM Works on central sleep apnoea, not obstructive. CSA is (approximately) caused by the central nervous system, while OSA is physical, and far more common. Permalink 15
Viewing a single comment thread. View all comments